Related references
Note: Only part of the references are listed.Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma
T. Facon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Prospective Validation of the Korean Cancer Study Group Geriatric Score (KG)-7, a Novel Geriatric Screening Tool, in Older Patients with Advanced Cancer Undergoing First-line Palliative Chemotherapy
Jin Won Kim et al.
CANCER RESEARCH AND TREATMENT (2019)
Predicting cumulative incidence of adverse events in older patients with cancer undergoing first-line palliative chemotherapy: Korean Cancer Study Group (KCSG) multicentre prospective study
Jin Won Kim et al.
BRITISH JOURNAL OF CANCER (2018)
Does my older cancer patient have cognitive impairment?
Jon Snaedal
JOURNAL OF GERIATRIC ONCOLOGY (2018)
Can we avoid the toxicity of chemotherapy in elderly cancer patients?
Jaime Feliu et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Expanding the Evidence Base in Geriatric Oncology: Action Items From an FDA-ASCO Workshop
Laura A. Levit et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Association between renal function and chemotherapy-related toxicity in older adults with cancer
Lindsay L. Peterson et al.
JOURNAL OF GERIATRIC ONCOLOGY (2017)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer
Arti Hurria et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement
Arti Hurria et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Predictors of chemotherapy dose reduction at first cycle in patients age 65 years and older with solid tumors
Ajeet Gajra et al.
JOURNAL OF GERIATRIC ONCOLOGY (2015)
Current palliative chemotherapy trials in the elderly neglect patient-centred outcome measures
Marlies L. van Bekkum et al.
JOURNAL OF GERIATRIC ONCOLOGY (2015)
Living too long
Guy C. Brown
EMBO REPORTS (2015)
Designing Therapeutic Clinical Trials for Older and Frail Adults With Cancer: U13 Conference Recommendations
Arti Hurria et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
Volker Heinemann et al.
LANCET ONCOLOGY (2014)
Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score
Martine Extermann et al.
CANCER (2012)
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Final Results of a Phase III Trial
Mark A. Socinski et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Development and validation of the Korean Nursing Delirium Scale
Kyoung-Nam Kim et al.
JOURNAL OF KOREAN ACADEMY OF NURSING (2012)
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
Arti Hurria et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial
Matthew T. Seymour et al.
LANCET (2011)
The Assessment and Management of Delirium in Cancer Patients
Shirley H. Bush et al.
ONCOLOGIST (2009)
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer:: A randomized phase III study
Leonard B. Saltz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy
Michelle Shayne et al.
CANCER (2007)
International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency
Stuart M. Lichtman et al.
EUROPEAN JOURNAL OF CANCER (2007)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
Alan Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Prognostic factors in advanced cancer patients:: Evidence-based clinical recommendations -: A study by the Steering Committee of the European Association for Palliative Care
M Maltoni et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Fast, systematic, and continuous delirium assessment in hospitalized patients: The Nursing Delirium Screening Scale
JD Gaudreau et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2005)
Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer
HB Muss et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
JH Schiller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Estimation of glomerular filtration rate in cancer patients
JG Wright et al.
BRITISH JOURNAL OF CANCER (2001)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Occurrence, causes, and outcome of delirium in patients with advanced cancer -: A prospective study
PG Lawlor et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
